Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07QDU
|
||||
| Former ID |
DNC014271
|
||||
| Drug Name |
1-benzhydryl-4-(4,4-diphenylbutyl)piperazine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530438] | ||
| Formula |
C33H36N2
|
||||
| Canonical SMILES |
C1CN(CCN1CCCC(C2=CC=CC=C2)C3=CC=CC=C3)C(C4=CC=CC=C4)C5=<br />CC=CC=C5
|
||||
| InChI |
1S/C33H36N2/c1-5-14-28(15-6-1)32(29-16-7-2-8-17-29)22-13-23-34-24-26-35(27-25-34)33(30-18-9-3-10-19-30)31-20-11-4-12-21-31/h1-12,14-21,32-33H,13,22-27H2
|
||||
| InChIKey |
MICPQZJRSOUTGV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Voltage-dependent calcium channel subunit alpha-2/delta-1 | Target Info | Inhibitor | [530438] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.